As of June 2024 Affimed has a market cap of $0.10 Billion. This makes Affimed the world's 7451th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $0.10 B | 9.96% |
2023 | $93.33 M | -49.6% |
2022 | $0.18 B | -72% |
2021 | $0.66 B | 15.8% |
2020 | $0.57 B | 173.33% |
2019 | $0.20 B | 7.61% |
2018 | $0.19 B | 234.34% |
2017 | $58.07 M | -3% |
2016 | $59.86 M | -74.72% |
2015 | $0.23 B | 59.25% |
2014 | $0.14 B |
On Jun 17th, 2024 the market cap of Affimed was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
Repligen
RGEN | $6.94 B | 6,669.89% | ๐บ๐ธ USA |
Merrimack Pharmaceuticals MACK | $0.22 B | 118.01% | ๐บ๐ธ USA |
Agenus
AGEN | $0.30 B | 192.59% | ๐บ๐ธ USA |
Acorda Therapeutics
ACOR | $0.82 M | -99.20% | ๐บ๐ธ USA |